Sheba Medical Center, Tel Aviv, Israel
Dr. Schapiro received his medical degree from Ben-Gurion University, and his Internship and Internal Medicine training at the Rabin Medical Center in Israel. Subsequently he completed a Fellowship in Infectious Diseases and Geographic Medicine at the Stanford University School of Medicine focusing on antiretroviral drug development at the Stanford Center for AIDS Research. His research has focused on the causes of antiretroviral drug failure, interventions to optimize clinical care, and new drug development. His interests include resistance and cross-resistance between drugs, clinical pharmacology, associations between resistance and pharmacology, and development of new antiretroviral agents with improved resistance and pharmacological characteristics. His publications have appeared in leading papers such as Annals of Internal Medicine and The Lancet. He continues his work with the Stanford HIV Drug Resistance Database and the Liverpool HIV Drug Interactions Website. Dr. Schapiro has served as a member and advisor of numerous US and international HIV expert panels and working groups including the United States Food and Drug Administration (FDA) Antiviral Drugs Advisory Committee, WHO Resistance Network, and the IAS-USA Drug Resistance Group. He currently runs the HIV/AIDS clinic at the National Hemophilia Center at Sheba Medical Center in Tel Aviv, and is very active in postgraduate educational programs for HIV treating physicians, in resource rich and limited settings.